A role for the stringent response in ciprofloxacin resistance in Pseudomonas aeruginosa

Libertad García-Villada1, Natalya P Degtyareva1, Ashley M Brooks2

  • 1Genomic Integrity and Structural Biology Laboratory, NIEHS, Durham, NC, USA.

Scientific Reports
|April 13, 2024
PubMed

Insights

Pseudomonas aeruginosa develops ciprofloxacin resistance through mutations in Stringent Response (SR) genes. These genetic changes, often short deletions, impact bacterial growth and highlight SR

Area of Science:

  • Microbiology
  • Molecular Biology
  • Antimicrobial Resistance Research

Background:

  • Pseudomonas aeruginosa is a significant cause of hospital-acquired infections and chronic lung infections in patients with cystic fibrosis and COPD.
  • P. aeruginosa exhibits high-level antibiotic resistance and rapidly acquires mutations for multi-drug resistance, complicating treatment.
  • Ciprofloxacin is a critical antibiotic for treating P. aeruginosa infections.

Purpose of the Study:

  • To investigate the genetic basis of ciprofloxacin resistance in P. aeruginosa.
  • To identify specific bacterial pathways involved in the acquisition of antibiotic resistance.
  • To understand the role of the Stringent Response (SR) in P. aeruginosa antibiotic resistance.

Main Methods:

  • P. aeruginosa strains were cultured on ciprofloxacin-containing agar plates.
  • Resistant colonies appearing after 48 hours of incubation were isolated and analyzed.
  • Genetic sequencing was performed to identify mutations in SR-related genes, particularly spoT.
  • Phenotypic characterization of resistant isolates included growth rate and intracellular ppGpp levels.

Main Results:

  • The majority of ciprofloxacin-resistant (ciproR) P. aeruginosa colonies carried mutations in Stringent Response (SR) genes.
  • Mutations in spoT, a key SR component, were found in approximately 40% of ciproR isolates.
  • Resistant isolates exhibited reduced growth rates, extended lag phases, and altered intracellular ppGpp levels compared to wild-type.
  • Insertions and deletions, predominantly short deletions, constituted 75% of the identified mutations.
  • Evidence suggests these mutations are induced on selective plates in a resistant subpopulation.

Conclusions:

  • The Stringent Response (SR) pathway is a significant contributor to the acquisition of ciprofloxacin resistance in P. aeruginosa.
  • Mutations in SR genes, like spoT, confer resistance and alter bacterial physiology.
  • Understanding SR's role in resistance can inform future therapeutic strategies against P. aeruginosa infections.